top of page
myLaminin Perspectives
Insights on Research Compliance, Clinical Trials & Data Management
ICH E6(R3) Clinical Trial Compliance: Is Your CTMS Ready for the Biggest Regulatory Shift in a Decade?
The new ICH E6(R3) guidelines are transforming clinical research worldwide, requiring Quality-by-Design, risk-based oversight, and validated digital systems. Discover how myLaminin's co-designed Clinical Trial Operations (CTOps) and CTMS platform helps research teams, principal investigators, administrators, and compliance professionals streamline operations, strengthen data integrity, improve audit readiness, and meet evolving global regulatory requirements with confidence.
Ash Bassili
Jun 194 min read
ICH E6 (R3) Is Here: What It Actually Means for Clinical Trials and Why It Matters Now
ICH E6 (R3) is reshaping clinical trial compliance across Canada, the U.S., EU, UK, and Australia. The updated Good Clinical Practice (GCP) guideline emphasizes Quality by Design, proactive risk management, audit trail traceability, sponsor oversight, informed consent, data integrity, and inspection readiness. myLaminin helps research teams and sponsors manage multi-site clinical trials with real-time oversight, CTQ monitoring, compliant eConsent, secure audit trails, and val
Deanne Bassili
May 74 min read
bottom of page